A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

NCT07029971 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated based on interim analysis results indicating the primary pharmacokinetic endpoint was unlikely to be met.

Conditions

Interventions

Sponsor

Vial Australia Pty Ltd